National Account Director, Enterprise Access

immunomeinc

United States

On-site

USD 180,000 - 280,000

Full time

14 days+

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

Immunome is seeking a highly experienced National Account Director, Enterprise Access to lead payer access strategy across the U.S. national footprint for our oncology portfolio.

You will build and sustain relationships with national and regional health plans, PBMs, and Key Account networks to advance launch readiness, coverage, formulary access, and therapeutic adoption after regulatory approval. The role requires deep expertise in payer analytics, Medicare Part D and Medicaid, and

Responsibilities

  • Develop and execute multi-year payer / PBM and Key Account plans.
  • Translate oncology market dynamics into national account priorities.
  • Build executive-level relationships with directors across plans and PBMs.
  • Navigate formularies and coverage policies across commercial plans, Medicare Part D, and Medicaid.
  • Lead negotiations and coordinate contract implementation with internal teams.

Skills

Payer access expertise
Executive relationship management
Enterprise account management
Cross-functional leadership
Medicare Part D & Medicaid knowledge

Job description

Company Overview

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been accepted by the U.S. FDA; IM-1021, a clinical-stage ROR1 ADC; IM-1617, a clinical-stage solid tumor ADC; IM-3050, a clinical-stage FAP-targeted radioligand therapy. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets.

Position Overview

Immunome is seeking a highly experienced and strategic National Account Director, Enterprise Access to lead integrated account strategy across a U.S. national footprint in support of our oncology portfolio. This role will build and sustain relationships with national and regional health plans, pharmacy benefit managers (PBMs), and Key Account customer networks to advance launch readiness, appropriate coverage and reimbursement, formulary access, and therapeutic adoption following regulatory approval.

The successful candidate will bring deep expertise in payer access and institutional purchasing, recognizing the distinct operating models, decision processes, and account economics of each. This position combines direct account ownership, strategic negotiation, and executive relationship management with cross-functional leadership, serving as a primary resource for field teams and connecting headquarters strategy with local execution.

Responsibilities
Strategic Leadership
  • Develop and execute multi-year Payer / PBM and Key Account institution plans with defined access objectives, stakeholder engagement, procurement strategies, and measures of success.
  • Apply commercial, Medicare Part D, and Medicaid expertise alongside community and integrated delivery network (IDN) business acumen, tailoring strategies to payer coverage decisions and provider purchasing structures.
  • Translate oncology market trends, clinical differentiation, reimbursement, and clinical pathway dynamics into national account priorities and commercial planning.
Payer Access and Stakeholder Management
  • Build executive-level relationships with pharmacy directors, medical directors, clinical leaders, and pharmacy and therapeutics (P&T) decision-makers across national and regional health plans and PBMs.
  • Navigate formulary and preferred drug list (PDL) development, utilization management, and coverage and reimbursement policies across commercial plans, Medicare Part D, and Medicaid fee‑for‑service (FFS) programs and managed care organizations (MCOs).
  • Map decision authority and payer affiliates; coordinate internal account teams to identify access barriers, align engagement, and advance appropriate coverage outcomes.
Institutional Access and Stakeholder Management
  • Build relationships with CEOs, CFOs, COOs, medical directors, pharmacists, and practice administrators across oncology customers and their member organizations.
  • Extend engagement to IDNs, health systems, hospital and community oncology networks, and national clinical pathway organizations, aligning corporate relationships with local customer needs.
  • Use approved clinical and economic evidence to support appropriate preferred formulary and pathway positioning with relevant provider and pathway decision-makers, respecting independent clinical decisions.
Strategic Negotiation
  • Lead payer, PBM, and community account strategy and negotiations, including pull‑through opportunity, within approved authority; balance coverage and purchasing objectives, rebate commitments, pricing dynamics, and long‑term business value.
  • Partner with Market Access, Finance, Legal, and Compliance to evaluate contract economics, 340B considerations, and Medicaid Best Price implications and secure approvals before commitments.
  • Prepare negotiation strategies for sophisticated counterparties, execute approved agreements, and coordinate implementation, performance monitoring, and renewals.
  • Translate local access and coverage landscape into coordinated field pull‑through plans, with clear account responsibilities and adherence to company policies.
Value Communication and Market Intelligence
  • Partner with Medical Affairs and health economics and outcomes research (HEOR) colleagues to translate clinical and economic evidence into account‑specific value narratives using approved materials and appropriate scientific support.
  • Tailor compliant communications to payer evidence needs, population priorities, and coverage considerations, and to Key Account, provider, and pathway stakeholders’ clinical and business priorities.
  • Monitor formularies, utilization management, coverage policies, clinical pathways, and oncology market developments; synthesize acco
Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

National Account Director, Enterprise Access
National Account Director, Enterprise Access

Immunome, Inc. • Bothell (WA)

On-site
USD 240,000 - 270,000
National Account Director, Enterprise Access
National Account Director, Enterprise Access

Immunome, Inc. • United States

Remote
USD 240,000 - 270,000
National Account Director, Enterprise Access (Oncology)
National Account Director, Enterprise Access (Oncology)

immunomeinc • United States

On-site
USD 180,000 - 280,000
National Account Director, Enterprise Access
National Account Director, Enterprise Access

Immunome • United States

Remote
USD 240,000 - 270,000
National Oncology Payer Access Director
National Oncology Payer Access Director

Immunome • United States

Remote
USD 240,000 - 270,000
Remote National Account & Payer Strategy Director
Remote National Account & Payer Strategy Director

Immunome, Inc. • United States

Remote
USD 240,000 - 270,000
National Account Director, Enterprise Access
National Account Director, Enterprise Access

Immunome, Inc. • Bothell (WA)

On-site
USD 240,000 - 270,000
Executive Director, Key Accounts Lead
Executive Director, Key Accounts Lead

Summit Therapeutics • United States

Hybrid
USD 180,000 - 260,000
IDN Strategic Account Director
IDN Strategic Account Director

Celltrion USA • United States

On-site
USD 150,000 - 230,000
Director, Oncology National Accounts
Director, Oncology National Accounts

Boehringer Ingelheim • Ridgefield (CT)

On-site
USD 230,000 - 345,000